Literature DB >> 24062207

Analysis of phyllodes tumor recurrence according to the histologic grade.

Sewha Kim1, Ji-Ye Kim, Do Hee Kim, Woo Hee Jung, Ja Seung Koo.   

Abstract

Local recurrence of phyllodes tumor (PT) of the breast is an adverse outcome that can result in sarcomatous degeneration. The aim of this study was to investigate the histologic and surgical factors associated with local recurrence. A total of 193 PT cases were studied: 145 (75.1 %) benign cases, 33 (17.1 %) borderline cases, and 15 (7.8 %) malignant cases. Stratifying our analysis according to histologic grade, we investigated the relationship between disease-free survival (DFS) and both histologic and surgical factors, including histologic grade, stromal cellularity, stromal atypia, stromal mitosis, stromal overgrowth, tumor margin, type of surgical procedure (local excision, wide excision, and mastectomy), surgical margin status, and radiation therapy. In the case of benign PT, all patients with local recurrences (3.4 %) had been treated with local excision, and all recurrent tumors were also benign. The local recurrence rate for locally excised benign PTs was not associated with surgical margin status or radiation therapy. In the case of borderline PT, local excision was associated with an increased local recurrence rate (P = 0.046). In malignant PT, small tumor size (≤4.0 cm) was associated with an increased local recurrence rate (P = 0.041). Univariate analyses indicated that surgical procedure (mastectomy < local excision < wide excision; P < 0.001) was significantly associated with shorter DFS in borderline PT. A positive surgical resection margin (P < 0.001) was associated with DFS in malignant PT. The factors associated with local recurrence differed with the histologic grade of PT, as did the features of local recurrence itself. In particular, benign PT had very low rate of local recurrence regardless of surgical margin status or radiation therapy, even when treated with local excision. In the case of benign PT, no recurrent tumors had worse histologic grades than the initial tumors.

Entities:  

Mesh:

Year:  2013        PMID: 24062207     DOI: 10.1007/s10549-013-2684-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  33 in total

Review 1.  Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways.

Authors:  Robert Y S Cheng; Debashree Basudhar; Lisa A Ridnour; Julie L Heinecke; Aparna H Kesarwala; Sharon Glynn; Christopher H Switzer; Stefan Ambs; Katrina M Miranda; David A Wink
Journal:  Nitric Oxide       Date:  2014-08-19       Impact factor: 4.427

2.  Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: A systematic review and meta-analysis.

Authors:  Shiyan Zeng; Xindan Zhang; Dejuan Yang; Xiaoyi Wang; Guosheng Ren
Journal:  Mol Clin Oncol       Date:  2015-02-06

3.  Surgical management of benign phyllodes tumours of the breast: Is wide local excision really necessary?

Authors:  Yiming Qian; May Lynn Quan; Travis Ogilvi; Antoine Bouchard-Fortier
Journal:  Can J Surg       Date:  2018-12-01       Impact factor: 2.089

4.  Recurrent borderline phyllodes tumor in nipple: a rare case report and review of the literature.

Authors:  Denghua Sun; Lu Tang; Hua Xing; Lijuan Zhang; Le Zhang
Journal:  Gland Surg       Date:  2020-04

5.  Phyllodes tumours of the breast: radiological presentation, management and follow-up.

Authors:  E McCarthy; J Kavanagh; Y O'Donoghue; E McCormack; C D'Arcy; S A O'Keeffe
Journal:  Br J Radiol       Date:  2014-10-01       Impact factor: 3.039

6.  Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.

Authors:  Philip M Spanheimer; Melissa P Murray; Emily C Zabor; Michelle Stempel; Monica Morrow; Kimberly J Van Zee; Andrea V Barrio
Journal:  Ann Surg Oncol       Date:  2019-02-19       Impact factor: 5.344

Review 7.  Width of margins in phyllodes tumors of the breast: the controversy drags on?-a systematic review and meta-analysis.

Authors:  Arnaud Toussaint; Romain Piaget-Rossel; Coraline Stormacq; Patrice Mathevet; Karine Lepigeon; Patrick Taffé
Journal:  Breast Cancer Res Treat       Date:  2020-09-15       Impact factor: 4.872

8.  Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.

Authors:  Thomas J Lawton; Geza Acs; Pedram Argani; Gelareh Farshid; Michael Gilcrease; Neal Goldstein; Frederick Koerner; J Jordi Rowe; Melinda Sanders; Sejal S Shah; Carol Reynolds
Journal:  Int J Surg Pathol       Date:  2014-08-26       Impact factor: 1.271

9.  Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.

Authors:  Su-Yang Liu; Nancy M Joseph; Ajay Ravindranathan; Bradley A Stohr; Nancy Y Greenland; Poonam Vohra; Elizabeth Hosfield; Iwei Yeh; Eric Talevich; Courtney Onodera; Jessica A Van Ziffle; James P Grenert; Boris C Bastian; Yunn-Yi Chen; Gregor Krings
Journal:  Mod Pathol       Date:  2016-06-03       Impact factor: 7.842

Review 10.  Phyllodes tumours of the breast: a consensus review.

Authors:  Benjamin Y Tan; Geza Acs; Sophia K Apple; Sunil Badve; Ira J Bleiweiss; Edi Brogi; José P Calvo; David J Dabbs; Ian O Ellis; Vincenzo Eusebi; Gelareh Farshid; Stephen B Fox; Shu Ichihara; Sunil R Lakhani; Emad A Rakha; Jorge S Reis-Filho; Andrea L Richardson; Aysegul Sahin; Fernando C Schmitt; Stuart J Schnitt; Kalliopi P Siziopikou; Fernando A Soares; Gary M Tse; Anne Vincent-Salomon; Puay Hoon Tan
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.